Cargando...
Near-infrared optical imaging in glioblastoma xenograft with ligand targeting α3 integrin
PURPOSE: Patients with glioblastoma usually have a very poor prognosis. Even with a combination of radiotherapy plus temozolomide, the median survival of these patients is only 14.6 months. New treatment approaches to this cancer are needed. Our purpose is to develop new cell-surface binding ligands...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2008
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2842018/ https://ncbi.nlm.nih.gov/pubmed/18712382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-008-0920-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|